跳至主要内容
临床试验/IRCT2014112920134N1
IRCT2014112920134N1已完成2 期

Study of the effect of vitamin D supplementation on outcome and prognostic biomarkers of VAP in patient with vitamin D deficiency

Chancellor for research, shahid beheshti medical university0 个研究点目标入组 46 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 no limit(—)
性别
All

入选标准

  • Patients over 18 years old, that clinically and based on the following criteria have been diagnosed with VAP (During the first 48 hours of diagnosis): The presence of new or progressive infiltration on the patient's chest radiograph that occur 48-72 hours after initiation of mechanical ventilation, While two of the following symptoms must be present with it: Fever over 38 ° C; leukocytosis or leukopenia (white blood cell count greater than 12,000 per µL of blood or less than 4000 per µL blood) and purulent pulmonary secretions.
  • Exclusion criteria: Stage3 or more chronic kidney problems; liver problems with CHILD-PUGH stage B or C; history of cancer within the last 3 months, or currently taking chemotherapy drugs; patients with immune deficiency; pancreatitis; other infections, concurrently with pneumonia caused by mechanical ventilation, patients with VAP that the vitamin D levels are normal and Coagulopathy.

排除标准

  • 未提供

研究者

发起方
Chancellor for research, shahid beheshti medical university

相似试验

Evaluation of vitamin D supplementation on outcome... | 临床试验